Clinical Trial Update: Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing iso-osmolar iodixanol with low-osmolar iohexol contrast agents in acute myocardial infarction patients undergoing primary PCI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Myocardial Infarction

Drugs mentioned

• OMNIPAQUE (iohexol)
• VISIPAQUE (IODIXANOL)

Snippet

Sponsor: Ospedale San Donato | Conditions: Contrast Induced Nephropathy, Acute Myocardial Infarction | Phase 4 | Status: COMPLETED